Market growth is driven by rising type 2 diabetes and obesity, an aging population, lifestyle changes, and new drug innovations.
WILMINGTON, DE, UNITED STATES, February 25, 2026 /EINPresswire.com/ — The global GLP-1 analogues market was valued …
GLP-1 Analogues Market to Reach USD 211.8 Bn by 2035 Amid Rising Diabetes and Obesity Cases |TMR
Recent Comments